SYNTHORIN - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
87695246
Word Mark
SYNTHORIN
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2022-01-31
Filing Date
2017-11-22
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2018-10-30
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
WEIGLE, KATHERINE CONN
Statements
Goods and Services
protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from cancer and autoimmune disorders; Protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, therapeutic agents in the nature of cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, anti-infectives, analgesics, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-12-05
Primary Code
005
Correspondences
Name
Karen Lim
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2017-11-25 | NEW APPLICATION ENTERED IN TRAM |
| 2017-12-05 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-03-07 | ASSIGNED TO EXAMINER |
| 2018-03-07 | NON-FINAL ACTION WRITTEN |
| 2018-03-07 | NON-FINAL ACTION E-MAILED |
| 2018-03-07 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2018-09-06 | EXAMINERS AMENDMENT -WRITTEN |
| 2018-09-06 | EXAMINERS AMENDMENT E-MAILED |
| 2018-09-06 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2018-09-06 | EXAMINER'S AMENDMENT ENTERED |
| 2018-09-10 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2018-09-23 | ASSIGNED TO LIE |
| 2018-10-10 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2018-10-30 | PUBLISHED FOR OPPOSITION |
| 2018-10-30 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2018-12-25 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2019-06-18 | TEAS EXTENSION RECEIVED |
| 2019-06-18 | EXTENSION 1 FILED |
| 2019-06-18 | EXTENSION 1 GRANTED |
| 2019-06-20 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2019-12-11 | TEAS EXTENSION RECEIVED |
| 2019-12-11 | EXTENSION 2 FILED |
| 2019-12-11 | EXTENSION 2 GRANTED |
| 2019-12-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-02-07 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-02-07 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-02-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2020-02-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2020-06-09 | TEAS EXTENSION RECEIVED |
| 2020-06-09 | EXTENSION 3 FILED |
| 2020-06-09 | EXTENSION 3 GRANTED |
| 2020-06-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-11-03 | TEAS EXTENSION RECEIVED |
| 2020-11-03 | EXTENSION 4 FILED |
| 2020-11-03 | EXTENSION 4 GRANTED |
| 2020-11-05 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2021-05-05 | TEAS EXTENSION RECEIVED |
| 2021-05-17 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2021-05-05 | EXTENSION 5 FILED |
| 2021-05-17 | EXTENSION 5 GRANTED |
| 2021-05-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2022-01-31 | ABANDONMENT - NO USE STATEMENT FILED |
| 2022-01-31 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
